Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up
The quarter's adjustments included certain amortization expenses, goodwill and other intangible asset impairment charges and acquisition/divestitures-related net charges, among others. Reported EPS for the second quarter was 53 cents, reflecting a 141% jump from the year-ago quarter's 22 cents.
Q2 Revenue Details of BSX
Revenues in the second quarter totaled $5.06 billion, up 22.8% year over year on a reported basis and 21.6% on an operational basis (at a constant exchange rate or CER). Organic growth, adjusted for foreign currency fluctuations and certain recent acquisitions and divestments, was 17.4%.
The top line surpassed the Zacks Consensus Estimate by 2.3%. and exceeded the company's Q2 revenue forecast of 17%-19%.
Following the earnings announcement, shares of BSX climbed 1.6% in pre-market trading today.
BSX's Q2 Revenues by Regions
In the second quarter, revenues rose 30.7% in the United States on a reported basis (same operationally).
Reported revenues rose 6.8% in the Europe, Middle East and Africa (EMEA) region (up 1.8% operationally) and 18% in the Asia Pacific zone (up 15.4% operationally).
Reported revenues increased 4% in Latin America and Canada (up 8.9% operationally). Reported revenue growth in emerging markets was 11.6% (up 12.1% operationally).
Breaking Down BSX's Q2 Revenues by Segments
Boston Scientific recently reorganized its operational structure and aggregated its core businesses into two reportable segments — MedSurg and Cardiovascular. Both these generate revenues from the sale of Medical Devices.
MedSurg
MedSurg revenues in the second quarter were $1.72 billion, up 15.7% year over year on a reported basis (up 7% organically).
Within this, the Endoscopy unit generated revenues of $737 million, up 7.8% organically.
Urology revenues were $679 million, reflecting organic growth of 6.3%.
The Neuromodulation business reported $303 million in revenues, highlighting a 6.6% rise organically year over year.
Cardiovascular
The company generates maximum revenues from this segment. Revenues in the second quarter came in at $3.35 billion, up 26.8% (reported) and 23.2% (organic) year over year.
Within this, Cardiology business sales totaled $2.65 billion (up 27.9% year over year organically) in the second quarter.
The Peripheral Interventions unit generated $698 million in sales, up 7%.
BSX's Margin Performance in Q2
The gross margin in the second quarter contracted 152 basis points (bps) year over year to 67.7%. There was a 28.9% rise in the cost of products sold to $1.63 billion in the reported quarter.
Selling, general and administrative expenses rose 18.7% to $1.72 billion. Research and development expenses rose 37.3% to $526 million. Royalty expenses of $14 million increased 55.6% year over year. The adjusted operating margin contracted 148 bps to 23.1% in the reported quarter.
BSX Updates 2025 Outlook, Shares Q3 View
For 2025, Boston Scientific now anticipates net sales to grow approximately 18-19% (compared with the earlier guidance of 15-17%) on a reported basis and 14-15% on an organic basis (earlier 12-14%). The Zacks Consensus Estimate is currently pegged at $19.50 billion, indicating a 16.4% rise from the 2024 reported figure.
Full-year adjusted EPS is expected in the range of $2.95-$2.99 (previously $2.87-$2.94). The Zacks Consensus Estimate for the same is currently pegged at $2.91.
For the third quarter of 2025, revenue growth is projected in the range of approximately 17-19% on a reported basis (up 12-14% organically). Adjusted earnings are expected in the range of 70-72 cents per share.
The Zacks Consensus Estimate for third-quarter earnings and revenues is pegged at 70 cents per share and $4.85 billion, respectively.
Our View on BSX Stock
Boston Scientific ended the second quarter of 2025 on a solid note, with both revenues and earnings beating the respective estimates. The performance reflected the strength of the company's product portfolio and the effectiveness of its highly engaged global team. Additionally, the raised sales and EPS guidance for the full year instill optimism. However, contraction of both margins in the quarter is concerning.
Boston Scientific achieved several milestones across its portfolio in the second quarter. It gained FDA approval to expand the labeling of its FARAPULSE PFA System for treating drug-refractory, symptomatic persistent atrial fibrillation (AF) and began enrollment in the ReMATCH IDE trial to evaluate its FARAWAVE and FARAPOINT PFA catheters in patients with recurrent persistent AF.
In Europe, the company secured CE Mark for the WATCHMAN FLX Pro device, designed to improve healing, visualization and anatomical fit. Boston Scientific also completed the acquisitions of Intera Oncology and SoniVie, strengthening its presence in liver cancer and hypertension treatment technologies.
BSX's Zacks Rank and Other Key Picks
Boston Scientific currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks from the broader medical space are Cencora COR, Veeva Systems VEEV and Resmed RMD.
Cencora, carrying a Zacks Rank #2, reported second-quarter fiscal 2025 adjusted EPS of $4.42, which beat the Zacks Consensus Estimate by 8.3%. Revenues of $75.45 billion beat the consensus mark by 0.8%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
COR has a historical average earnings growth rate of 13.8% compared with the industry's 1% growth. The company surpassed earnings estimates in each of the trailing four quarters, with the average surprise being 6%.
Veeva Systems, carrying a Zacks Rank #2 at present, posted first-quarter fiscal 2026 adjusted EPS of $1.97, exceeding the Zacks Consensus Estimate by 13.2%. Revenues of $759 million surpassed the Zacks Consensus Estimate by 4.3%.
VEEV has an estimated long-term earnings growth rate of 23.3% compared with the industry's 17.9% growth. The company's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 10%.
Resmed, currently carrying a Zacks Rank #2, reported third-quarter fiscal 2025 adjusted EPS of $2.30, which surpassed the Zacks Consensus Estimate by 0.4%. Revenues of $1.29 billion topped the Zacks Consensus Estimate by 0.5%.
RMD has an estimated long-term earnings growth rate of 15.3% compared with the industry's 14% growth. The company's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 4.2%.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Veeva Systems Inc. (VEEV): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
27 minutes ago
- Globe and Mail
Levi & Korsinsky Notifies Reckitt Benckiser Group plc (RBGLY) Investors - Lead Plaintiff Deadline on August 4, 2025
New York, New York--(Newsfile Corp. - July 25, 2025) - If you suffered a loss on your Reckitt Benckiser Group plc (OTCQX: RBGLY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Reckitt Benckiser Group plc that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) preterm infants were at an increased risk of developing NEC by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. WHAT'S NEXT? If you suffered a loss in Reckitt Benckiser Group plc stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes. To view the source version of this press release, please visit
Globe and Mail
an hour ago
- Globe and Mail
USA Hospitality Sector Adopts Professional Services Automation With IBN Technologies Support
"professional services automation [USA]" Hospitality businesses in the USA are enhancing operational efficiency and service delivery through professional services automation. From improving guest services to streamlining back-office tasks, companies are automating workflows and achieving better outcomes. The content outlines successful use cases, challenges resolved, and how expert-led ERP solutions are enabling industry-wide transformation. Miami, Florida - 25 July, 2025 - Hotels, resorts, and service-oriented venues in the U.S. hospitality sector are adopting advanced systems that refine financial oversight and guest services. Operators are turning to external specialists to optimize administrative loads, allowing internal teams to focus on delivering consistent guest experiences. Many hospitality businesses are now investing in professional services automation to ensure smoother coordination between departments and timely financial reporting. Several property groups have begun outsourcing functions like billing, accounts management, and vendor coordination. These efforts align with broader digital strategies focused on reducing bottlenecks and improving operational agility. Process automation is increasingly integrated into back-office workflows to reduce repetitive tasks and improve invoice accuracy. Firms that deploy structured outsourcing models notice stronger service continuity and better staff productivity in high-volume periods. The hospitality industry's renewed interest in support stems from the need to manage rising costs without compromising service quality. With enhanced tools and automated systems, operators are targeting clear business outcomes, such as faster reconciliation cycles and reliable vendor communications. As companies look ahead, those leaning on external financial expertise with built-in process intelligence are achieving measurable efficiency and setting new benchmarks for hospitality performance. Power your payables through automation. Get a Free Consultation: Manual Process Challenges Mount Rising operational costs and inflationary pressures are creating tighter margins for hospitality businesses in the USA. Without automated support, hotels and service providers are finding it difficult to maintain efficiency and accuracy while managing high guest expectations and vendor demands. Frequent billing discrepancies affecting vendor trust Delayed invoice approvals are causing payment backlogs Time-consuming reconciliation is slowing monthly closings High staff turnover impacting process consistency Manual data entry increases error risks Poor visibility into spending across departments Lack of centralized systems causes communication delays Difficulty scaling operations during peak periods To address these gaps, financial experts are helping hospitality operators transition to structured support models that remove unnecessary workload. Specialized firms deliver managed solutions backed by professional services automation, reducing the time spent on manual approvals, reporting, and supplier coordination. These frameworks are enabling teams to manage rising costs with greater control while maintaining smooth internal operations. Automation Services for Hospitality Hospitality operators in the U.S. are turning to automation solutions to resolve recurring process inefficiencies and deliver consistent service experiences. Industry experts are working closely with property managers, resorts, and chains to deploy streamlined systems that reduce errors, improve timelines, and control administrative overhead. • Automated front desk and check-in/check-out processing systems • Guest reservation management integrated with real-time room availability • Digital concierge services to enhance guest interaction and satisfaction • Centralized invoice approval and automated billing reconciliation workflows • Procurement automation connected with vendor payment scheduling systems • Automated payroll processing for hotel and service staff across locations • Dynamic pricing tools linked with booking and revenue platforms • Housekeeping task allocation and tracking via digital dashboards • Customer feedback collection automated through post-stay surveys • Inventory management automation for food, linens, and minibar restocking Many organizations are selecting automation-led models to keep operations lean while ensuring responsiveness. With professional services automation in the USA, firms can align financial accuracy with guest satisfaction. Specialists in the space, like IBN Technologies, offer personalized automation frameworks that help hospitality businesses operate efficiently and meet rising service demands with confidence. Proven Gains in Hospitality Automation Hospitality providers in the USA are reporting measurable outcomes after implementing professional services automation to address operational gaps. By automating complex workflows and integrating financial systems, hotels and resorts are seeing higher efficiency and stronger accuracy in daily operations. Order entry time has dropped by two-thirds—from 7 minutes to just 2. Accuracy in booking and billing has increased significantly across U.S. properties. Over 80% of recurring service tasks are now automated nationwide. 100% accountability achieved through end-to-end tracking of responsibilities. These results highlight how the hospitality industry in the USA is advancing through structured automation solutions. Process consistency, cost reduction, and faster service cycles are now well within reach for firms adopting tailored automation frameworks. Hospitality Embraces Intelligent Operations U.S. hospitality operators are reaching new performance benchmarks by moving toward structured digital frameworks that reduce inefficiencies and elevate service consistency. From guest engagement to back-office finance, more businesses are achieving clarity and control by implementing professional services automation. Decision-makers are aligning internal goals with results-driven systems that support long-term scalability. With consistent improvements seen in accuracy, speed, and team productivity, many are accelerating their adoption of AI and Automation to remain competitive. Hotels, resorts, and service-based venues are seeing the benefits of integrated workflows—where real-time data, streamlined approvals, and automated routines reduce manual bottlenecks. These tools are giving businesses the agility to respond faster, deliver better guest experiences, and maintain financial precision under growing demand. Companies like IBN Technologies are leading this shift through ERP systems and industry-aligned solutions. Their structured approach is helping hospitality businesses make decisive moves in optimizing workflows. As the sector advances, teams embracing automation and expert-led services are gaining measurable advantages in operational performance and service delivery. Related Services: About IBN Technologies IBN Technologies LLC, an outsourcing specialist with 26 years of experience, serves clients across the United States, United Kingdom, Middle East, and India. Renowned for its expertise in RPA, Intelligent process automation includes AP Automation services like P2P, Q2C, and Record-to-Report. IBN Technologies provides solutions compliant with ISO 9001:2015, 27001:2022, and GDPR standards. The company has established itself as a leading provider of IT, KPO, and BPO outsourcing services in finance and accounting, including CPAs, hedge funds, alternative investments, banking, travel, human resources, and retail industries. It offers customized solutions that drive AR efficiency and growth.
Globe and Mail
an hour ago
- Globe and Mail
Rosen Law Firm Urges Luminar Technologies, Inc. (NASDAQ: LAZR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Luminar Technologies, Inc. (NASDAQ: LAZR) securities between March 20, 2025 and May 14, 2025, both dates inclusive (the 'Class Period'). Luminar purports to be a technology company that specializes in advanced 'Light Detection and Ranging' ('LiDAR') hardware and software solutions for vehicles. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Luminar Technologies, Inc. (NASDAQ: LAZR) Misled Investors Regarding its Business Operations. According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Austin Russell ('Russell'), Luminar's President, CEO and Chairman of the Board, was engaged in undisclosed conduct that would make him the subject of an inquiry by the Audit Committee of the Board of Directors; (2) this conduct created material risk that Russell would be released form his positions at Luminar; (3) Luminar's loss of Russell as an employee would then create material risk of adversely affecting Luminar's business by making it more difficult to compete with other market participants, manage R&D activities, and retain existing customers or cultivate new ones. Further, negative public perception and negative news related to Russell could adversely affect Luminar's brand relationships with customers, or standing in the industry; (4) accordingly, Luminar had no reasonable basis to provide and/or maintain Luminar's financial guidance; and (5) as a result, defendants' public statements were materially false and/or misleading at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Luminar Technologies, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by September 22, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.
